Merit Medical Systems Inc (MMSI)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.30 (-0.29%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.

Key Insights

Critical company metrics and information
  • Share Price

    $104.40
  • Market Cap

    $6.08 Billion
  • Total Outstanding Shares

    58.28 Million Shares
  • Total Employees

    6,950
  • Dividend

    No dividend
  • IPO Date

    February 26, 1992
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.merit.com

Historical Stock Splits

If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution DateSplit Amount
May 6, 20115-for-4
December 3, 20034-for-3
August 15, 20034-for-3

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$462.13 Million
Net Cash Flow From Operating Activities, Continuing$214.31 Million
Net Cash Flow$462.13 Million
Net Cash Flow From Financing Activities$410.37 Million
Net Cash Flow From Operating Activities$214.31 Million
Net Cash Flow From Investing Activities$-162.55 Million
Net Cash Flow From Investing Activities, Continuing$-162.55 Million
Net Cash Flow From Financing Activities, Continuing$410.37 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Income/Loss$120.04 Million
Revenues$1.33 Billion
Operating Income/Loss$152.74 Million
Selling, General, and Administrative Expenses$384.41 Million
Diluted Earnings Per Share$2.05
Net Income/Loss Available To Common Stockholders, Basic$120.04 Million
Diluted Average Shares$118.20 Million
Net Income/Loss Attributable To Parent$120.04 Million
Provision For Loan, Lease, And Other Losses$1.27 Million
Income Tax Expense/Benefit$28.28 Million
Operating Expenses$468.14 Million
Other Operating Expenses$83.73 Million
Preferred Stock Dividends And Other Adjustments$0.00
Benefits Costs and Expenses$1.18 Billion
Gross Profit$620.88 Million
Costs And Expenses$1.18 Billion
Income/Loss From Continuing Operations After Tax$120.04 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Nonoperating Income/Loss$-4.43 Million
Basic Earnings Per Share$2.07
Cost Of Revenue$704.99 Million
Basic Average Shares$116.35 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income/Loss From Continuing Operations Before Tax$148.31 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Liabilities$1.05 Billion
Current Assets$1.08 Billion
Equity Attributable To Parent$1.32 Billion
Assets$2.38 Billion
Long-term Debt$750.50 Million
Liabilities And Equity$2.38 Billion
Inventory$310.53 Million
Equity$1.32 Billion
Fixed Assets$389.65 Million
Other Non-current Assets$910.11 Million
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Liabilities$853.60 Million
Current Liabilities$201.08 Million
Other Current Assets$767.79 Million
Other Non-current Liabilities$103.09 Million
Noncurrent Assets$1.30 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.